HomeAvita Medical

Avita Medical

Avita Medical Announces Positive Results from Pivotal Trial Highlights

These data will be submitted to the U.S. Food and Drug Administration as part of an application to support Premarket Approval (PMA) for the ReCell® Autologous Cell Harvesting device.

By using this website you agree to accept Medical Device News Magazine Privacy Policy